Lung Cancer Clinical Trial
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Summary
This study will summarize the safety of patients receiving figitumumab combined with etoposide and cisplatin (or carboplatin) vs. patients receiving etoposide and cisplatin (or carboplatin) alone as first line treatment for extensive stage disease Small Cell Lung Cancer.
Full Description
The study prematurely discontinued on January 26, 2011 due to slow enrollment. It should be noted that safety concerns have not been seen in this study and have not factored into this decision.
Eligibility Criteria
Inclusion Criteria:
Histologically confirmed diagnosis of extensive stage disease Small Cell Lung Cancer (SCLC), with tumor biopsy sample required.
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. Total IGF-1 > or = 120 ng/ml
Exclusion Criteria:
Any prior systemic therapy for Small Cell Lung Cancer (SCLC)
HbA1c > or = 5.7%
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 49 Locations for this study
Washington District of Columbia, 20007, United States
Washington District of Columbia, 20007, United States
Marrero Louisiana, 70072, United States
Metairie Louisiana, 70006, United States
Creve Coeur Missouri, 63141, United States
St. Louis Missouri, 63110, United States
St. Louis Missouri, 63110, United States
St. Peters Missouri, 63376, United States
Morristown New Jersey, 07962, United States
Hickory North Carolina, 28602, United States
Kernersville North Carolina, 27284, United States
Lenoir North Carolina, 28645, United States
Lexington North Carolina, 27295, United States
Mount Airy North Carolina, 27030, United States
North Wilkesboro North Carolina, 28659, United States
Winston-Salem North Carolina, 27103, United States
Beaverton Oregon, 97006, United States
Gresham Oregon, 97030, United States
Portland Oregon, 97210, United States
Portland Oregon, 97239, United States
Tualatin Oregon, 97062, United States
West Reading Pennsylvania, 19611, United States
Christiansburg Virginia, 24074, United States
Low Moor Virginia, 24457, United States
Roanoke Virginia, 24014, United States
Salem Virginia, 24153, United States
Wytheville Virginia, 24382, United States
Everett Washington, 98201, United States
Federal Way Washington, 98003, United States
Gig Harbor Washington, 98332, United States
Kennewick Washington, 99336, United States
Lakewood Washington, 98499, United States
Puyallup Washington, 98372, United States
Tacoma Washington, 98405, United States
Oshawa Ontario, L1G 2, Canada
Sudbury Ontario, P3E 5, Canada
Levis Quebec, G6V 3, Canada
Montreal Quebec, H4J 1, Canada
Budapest , 1125, Hungary
Debrecen , 4032, Hungary
Deszk , 6772, Hungary
Farkasgyepu , 8582, Hungary
Torokbalint , 2045, Hungary
Barcelona , 08025, Spain
Barcelona , 08036, Spain
Las Palmas de Gran Canaria , 35016, Spain
Madrid , 28041, Spain
Malaga , 29010, Spain
Sevilla , 41009, Spain
Sevilla , 41013, Spain
Valencia , 46026, Spain
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.